Ironwood Pharmaceuticals IRWD
NASDAQ IRWD
$4.87 +0.06 (+1.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Ironwood Pharmaceuticals (IRWD) Return on Sales [ROS] (2009 - 2026)

Updated

Ironwood Pharmaceuticals (IRWD) posted Return on Sales [ROS] of 70.16% for Q2 2026, up 16.99 percentage points from 53.17% a year earlier and up 2.02 percentage points from the prior quarter.

Analysis

Ironwood Pharmaceuticals (IRWD) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Ironwood Pharmaceuticals was 60.15%, up 36.38 percentage points year-over-year; for FY2025, it came in at 33.26%, up 6.76 percentage points from FY2024.

  • Annual Return on Sales [ROS] shows a five-year change of -3.44 percentage points (FY2020 to FY2025).
  • In prior years, Ironwood Pharmaceuticals' Return on Sales [ROS] was 26.50% in FY2024 (+240.04 pp), -213.54% in FY2023 (-274.51 pp), 60.97% in FY2022 (+4.83 pp) and 56.13% in FY2021 (+19.44 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Sales [ROS] since Q4 2017.
  • On a year-over-year basis, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of +13.26 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2024, with a gain of 1035.14 percentage points; the weakest was Q2 2023, with a drop of 1065.92 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 68.14% (Q1 2026), 14.26% (Q4 2025) and 61.84% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Ironwood Pharmaceuticals 796.30 Mn 194.87 Mn - 70.00%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 70.00%
Jun 30, 2026 70.16%
Mar 31, 2026 68.14%
Dec 31, 2025 14.26%
Sep 30, 2025 61.84%
Jun 30, 2025 53.17%
Mar 31, 2025 -70.75%
Dec 31, 2024 34.78%
Sep 30, 2024 27.99%
Jun 30, 2024 26.46%
Mar 31, 2024 14.72%
Dec 31, 2023 31.98%
Sep 30, 2023 35.19%
Jun 30, 2023 -1,008.68%
Mar 31, 2023 57.75%
Dec 31, 2022 63.77%
Sep 30, 2022 63.03%
Jun 30, 2022 57.24%
Mar 31, 2022 59.31%
Dec 31, 2021 48.32%
API Access

Ironwood Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IRWD&period=max&api_key=YOUR_API_KEY